Arvee Laboratories (India)
Arvee Laboratories (India) Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Arvee Laboratories (India)
Start SIPArvee Laboratories (India) Investment Rating
-
Master Rating:
-
Arvee Laboratories (India) has an operating revenue of Rs. 69.73 Cr. on a trailing 12-month basis. An annual revenue de-growth of -15% needs improvement, Pre-tax margin of 9% is okay, ROE of 10% is good. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 25% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 95 which is a GREAT score indicating consistency in earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 120 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 13 | 16 | 23 | 18 | 13 |
| Operating Expenses Qtr Cr | 11 | 15 | 19 | 16 | 11 |
| Operating Profit Qtr Cr | 1 | 2 | 3 | 2 | 2 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 1 | 1 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 1 | 0 | 1 | 0 | 0 |
| Net Profit Qtr Cr | 0 | 1 | 2 | 1 | 1 |
Arvee Laboratories (India) Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- ₹110.34
- 50 Day
- ₹109.44
- 100 Day
- ₹107.92
- 200 Day
- ₹104.77
- 20 Day
- ₹111.49
- 50 Day
- ₹108.09
- 100 Day
- ₹106.75
- 200 Day
- ₹104.03
Arvee Laboratories (India) Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹110.29 |
| Second Resistance | ₹111.62 |
| Third Resistance | ₹112.74 |
| RSI | 44.79 |
| MFI | 48.59 |
| MACD Single Line | -0.11 |
| MACD | -0.86 |
| Support | |
|---|---|
| First Resistance | ₹107.84 |
| Second Resistance | ₹106.72 |
| Third Resistance | ₹105.39 |
Arvee Laboratories (India) Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 369 | 24,199 | 65.58 |
| Week | 460 | 33,038 | 71.76 |
| 1 Month | 924 | 48,888 | 52.89 |
| 6 Month | 2,202 | 173,235 | 78.68 |
Arvee Laboratories (India) Result Highlights
Arvee Laboratories (India) Synopsis
NSE-Chemicals-Specialty
Arvee Laboratories belongs to the Industry of Chemicals - Speciality - Others. Company’s Total Operating Revenue is Rs. 40.33 Cr. and Equity Capital is Rs. 11.02 Cr. for the Year ended 31/03/2022. Arvee Laboratories (India) Ltd. is a Public Limited Listed company incorporated on 27/01/2012 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ2012PLC068778 and registration number is 068778.| Market Cap | 118 |
| Sales | 70 |
| Shares in Float | 0.29 |
| No of funds | |
| Yield |
| Book Value | 4.91 |
| U/D Vol ratio | 0.5 |
| LTDebt / Equity | 4 |
| Alpha | 0.11 |
| Beta | 0.4 |
Arvee Laboratories (India)
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 73.5% | 73.5% | 73.5% | 73.5% |
| Mutual Funds | ||||
| Insurance Companies | ||||
| Foreign Portfolio Investors | ||||
| Financial Institutions/ Banks | ||||
| Individual Investors | 26.36% | 26.34% | 26.3% | |
| Others | 0.14% | 0.16% | 0.2% | 26.5% |
Arvee Laboratories (India) Management
| Name | Designation |
|---|---|
| Mr. Shalin Sudhakarbhai Patel | Managing Director |
| Mr. Shalin Bharat Chokshi | Whole Time Director |
| Mrs. Neetu Rishi Jalan | Independent Director |
| Mr. Dipen Ashit Dalal | Independent Director |
| Mr. Vishal Nitin Mehta | Independent Director |
| Mr. Sachin Kanwarlal Kansal | Independent Director |
Arvee Laboratories (India) Forecast
Price Estimates
Arvee Laboratories (India) Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-05 | Audited Results | |
| 2023-02-02 | Quarterly Results | |
| 2022-11-11 | Quarterly Results | |
| 2022-08-02 | Quarterly Results | |
| 2022-05-26 | Audited Results |
Arvee Laboratories (India) FAQs
What is Share Price of Arvee Laboratories (India) ?
Arvee Laboratories (India) share price is ₹105 As on 03 June, 2023 | 09:50
What is the Market Cap of Arvee Laboratories (India) ?
The Market Cap of Arvee Laboratories (India) is ₹116.5 Cr As on 03 June, 2023 | 09:50
What is the P/E ratio of Arvee Laboratories (India) ?
The P/E ratio of Arvee Laboratories (India) is 28.3 As on 03 June, 2023 | 09:50
What is the PB ratio of Arvee Laboratories (India) ?
The PB ratio of Arvee Laboratories (India) is 4.9 As on 03 June, 2023 | 09:50